1. The Role of TAM Family Receptors in Immune Cell Function: Implications for Cancer Therapy
   Magdalena Paolino et al, 2016, Cancers CrossRef
2. Apigenin inhibits glioma cell growth through promoting microRNA-16 and suppression of BCL-2 and nuclear factor-κB/MMP-9
   Xin-Jun Chen et al, 2016 CrossRef
3. miR-124 inhibits proliferation and invasion of human retinoblastoma cells by targeting STAT3
   Shu Liu et al, 2016 CrossRef
4. Apigenin inhibits proliferation and invasion, and induces apoptosis and cell cycle arrest in human melanoma cells
   Guangming Zhao et al, 2017 CrossRef
5. The metabolic cross-talk between epithelial cancer cells and stromal fibroblasts in ovarian cancer progression: Autophagy plays a role
   Chanitra Thuwajit et al, 2017, Med Res Rev CrossRef
6. Apigenin in cancer therapy: anti-cancer effects and mechanisms of action
   Xiaohui Yan et al, 2017, Cell Biosci CrossRef
7. Plant Flavone Apigenin: an Emerging Anticancer Agent
   Eswar Shankar et al, 2017, Curr Pharmacol Rep CrossRef
8. Apigenin: A dietary flavonoid with diverse anticancer properties
   Josip Madunić et al, 2018, Cancer Letters CrossRef
9. Targeting the IL-6/JAK/STAT3 signalling axis in cancer.
   Daniel E Johnson et al, 2018, Nat Rev Clin Oncol CrossRef
10. Transcriptome-based signature predicts the effect of taxol in serous ovarian cancer
    Shunyu Hou et al, 2018, PLoS ONE CrossRef
11. pSTAT3 Levels Have Divergent Expression Patterns and Associations with Survival in Squamous Cell Carcinoma and Adenocarcinoma of the Oesophagus
    Katie O’ Sullivan et al, 2018, IJMS CrossRef
12. Apigenin: A natural bioactive flavone-type molecule with promising therapeutic function
    Dharambir Kashyap et al, 2018, Journal of Functional Foods CrossRef
13. null
    Elizabeth Cedars et al, 2018 CrossRef
14. Flavones modulate respiratory epithelial innate immunity: Anti-inflammatory effects and activation of the T2R14 receptor
    Benjamin M. Hariri et al, 2017, J. Biol. Chem. CrossRef
15. The Emerging Role of TYRO3 as a Therapeutic Target in Cancer
    Sherri Smart et al, 2018, Cancers CrossRef
16. Midkine silencing enhances the anti–prostate cancer stem cell activity of the flavone apigenin: cooperation on signaling pathways regulated by ERK, p38, PTEN, PARP, and NF-κB
    Suat Erdogan et al, 2019, Invest New Drugs CrossRef
17. α-Mangostin and Apigenin Induced Cell Cycle Arrest and Programmed Cell Death in SKOV-3 Ovarian Cancer Cells
    Teeranai Ittiudomrak et al, 2019, ToxicolRes CrossRef
18. Epigenetic inhibition of the tumor suppressor ARHI by light at night-induced circadian melatonin disruption mediates STAT3-driven paclitaxel resistance in breast cancer.
    Shulin Xiang et al, 2019, J Pineal Res CrossRef
19. Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids
    Qingmei Ye et al, 2019, Front. Oncol. CrossRef
20. MiR-34a suppresses ovarian cancer proliferation and motility by targeting AXL
    Rui Li et al, 2015, Tumor Biol. CrossRef
21. null
    Derek W. Edwardson et al, 2019 CrossRef
22. Inhibition of JAK2 Reverses Paclitaxel Resistance in Human Ovarian Cancer Cells
    Yefang Xu et al, 2015, Int J Gynecol Cancer CrossRef
23. Novel Recombinant Protein FlaA N/C Protects against Radiation Injury via NF-κB Signaling
    Ying Xu et al, 2015, Radiation Research CrossRef
24. Gene of the month:Axl
    Matthew Brown et al, 2016, J Clin Pathol CrossRef
25. Metabolic Variations of Flavonoids in Leaves of T. media and T. mairei Obtained by UPLC-ESI-MS/MS
    Tao Wang et al, 2019, Molecules CrossRef
26. Health functionality of apigenin: A review
    Fahad Ali et al, 2017, International Journal of Food Properties CrossRef
27. STAT3 targeting by polyphenols: Novel therapeutic strategy for melanoma
    Saeideh Momtaz et al, 2017, BioFactors CrossRef
28. Apigenin: A current review on its beneficial biological activities
    Xiang Zhou et al, 2017, J Food Biochem CrossRef
29. The potential and controversy of targeting STAT family members in cancer.
    Yannick Verhoeven et al, 2020, Semin Cancer Biol CrossRef
30. Interleukin-6 mediates resistance to PI3K-pathway-targeted therapy in lymphoma.
    Joo Hyun Kim et al, 2019, BMC Cancer CrossRef
31. Novel activators and small-molecule inhibitors of STAT3 in cancer
    Lehe Yang et al, 2019, Cytokine & Growth Factor Reviews CrossRef
32. Apigenin, A Plant Flavone Playing Noble Roles in Cancer Prevention Via Modulation of Key Cell Signaling Networks
    Deepti Singh et al, 2020, PRA CrossRef
33. null
    Nellie K. McDaniel et al, 2020 CrossRef
34. Investigation Of Possible Effects Of Apigenin, Sorafenib and Combined Applications On Apoptosis And Cell Cycle In Hepatocellular Cancer Cells
    Nazlı Şirin et al, 2020, Gene CrossRef
35. Apigenin as an anticancer agent.
    Muhammad Imran et al, 2020, Phytother Res CrossRef
36. IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells
    Xiaolan Zhu et al, 2017, Oncotarget CrossRef
37. Axl inhibition induces the antitumor immune response which can be further potentiated by PD-1 blockade in the mouse cancer models
    Zhiqiang Guo et al, 2017, Oncotarget CrossRef
38. Integrative radiogenomic analysis for multicentric radiophenotype in glioblastoma
    Doo-Sik Kong et al, 2016, Oncotarget CrossRef
39. Physapubescin B inhibits tumorgenesis and circumvents taxol resistance of ovarian cancer cells through STAT3 signaling
    Xiaofeng Zhao et al, 2017, Oncotarget CrossRef
40. A novel application of E1A in combination therapy with EGFR-TKI treatment in breast cancer
    Chih-Ming Su et al, 2016, Oncotarget CrossRef
41. TAM receptors Tyro3 and Mer as novel targets in colorectal cancer
    Robin Schmitz et al, 2016, Oncotarget CrossRef
42. Interleukin-6 expression contributes to lapatinib resistance through maintenance of stemness property in HER2-positive breast cancer cells
    Wei-Chien Huang et al, 2016, Oncotarget CrossRef
43. Immunotherapies in ovarian cancer
    Elena García-Martínez et al, 2020, European Journal of Cancer Supplements CrossRef
44. Ginsenoside 3β-O-Glc-DM (C3DM) enhances the antitumor activity of Taxol on Lewis lung cancer by targeting the interleukin-6/Jak2/STAT3 and interleukin-6/AKT signaling pathways
    Mei Tang et al, 2020, World J Tradit Chin Med CrossRef
45. Inhibition of AXL enhances chemosensitivity of human ovarian cancer cells to cisplatin via decreasing glycolysis.
    Min Tian et al, 2021, Acta Pharmacol Sin CrossRef
46. Phytoestrogens for Cancer Prevention and Treatment
    Margalida Torrens-Mas et al, 2020, Biology CrossRef
47. Flavonoids Regulate Inflammation and Oxidative Stress in Cancer
    Guangxing Li et al, 2020, Molecules CrossRef
48. Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype
    Susan R. Mallery et al, 2017, Cancer Prev Res CrossRef
49. Polyphenolic molecules targeting signal transducer and activator of transcription 3 pathway for the treatment of cancer
    Md. Abdul Aziz et al, 2021, Life Sciences CrossRef
50. Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
    Luciana Mosca et al, 2021, Drug Resistance Updates CrossRef
51. Quercetin Induces Apoptosis in Glioblastoma Cells by Suppressing Axl/IL-6/STAT3 Signaling Pathway
    Hyo In Kim et al, 2021, Am. J. Chin. Med. CrossRef
52. Identification of signalling pathways activated by Tyro3 that promote cell survival, proliferation and invasiveness in human cancer cells
    Nour Al Kafri et al, 2021, Biochemistry and Biophysics Reports CrossRef
53. Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2
    Tatyana Novoyatleva et al, 2021, Commun Biol CrossRef
54. The implication of IL-6 in the invasiveness and chemoresistance of ovarian cancer cells. Systematic review of its potential role as a biomarker in ovarian cancer patients
    Szulc-Kielbik Izabela et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
55. Rationalizing the therapeutic potential of apigenin against cancer
    Semim Akhtar Ahmed et al, 2021, Life Sciences CrossRef
56. null
    Alexander V. Sirotkin et al, 2022 CrossRef
57. Anticancer Effects and Molecular Mechanisms of Apigenin in Cervical Cancer Cells.
    Ya-Hui Chen et al, 2022, Cancers (Basel) CrossRef
58. Insights into the role of STAT3 in intrahepatic cholangiocarcinoma (Review)
    Ranzhiqiang Yang et al, 2022, Mol Med Rep CrossRef
59. Effects of Melatonin and Doxorubicin on Primary Tumor And Metastasis in Breast Cancer Model
    Gamze Tanriover et al, 2022, ACAMC CrossRef
60. Comprehensive analysis of the prognostic and immunotherapeutic implications of STAT family members in human colorectal cancer
    Dingchang Li et al, 2022, Front. Genet. CrossRef
61. Targeting Tyrosine Kinases in Ovarian Cancer: Small Molecule Inhibitor and Monoclonal Antibody, Where Are We Now?
    Aimee Rendell et al, 2022, Biomedicines CrossRef
62. Modern aspects of the use of natural polyphenols in tumor prevention and therapy
    Galina Sufianova et al, 2022, Front. Cell Dev. Biol. CrossRef
63. The Potential Role of Apigenin in Cancer Prevention and Treatment
    Arshad Husain Rahmani et al, 2022, Molecules CrossRef
64. Crosstalk between extracellular vesicles and tumor-associated macrophage in the tumor microenvironment
    Qiao Yi Chen et al, 2022, Cancer Letters CrossRef
65. A Receptor Tyrosine Kinase Inhibitor Sensitivity Prediction Model Identifies AXL Dependency in Leukemia
    Ahmad Nasimian et al, 2023, IJMS CrossRef